Home Cart Sign in  
Chemical Structure| 863329-66-2 Chemical Structure| 863329-66-2

Structure of PSI-6206
CAS No.: 863329-66-2

Chemical Structure| 863329-66-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.

Synonyms: GS-331007; RO 2433

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PSI-6206

CAS No. :863329-66-2
Formula : C10H13FN2O5
M.W : 260.22
SMILES Code : C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=CC(=O)NC1=O
Synonyms :
GS-331007; RO 2433
MDL No. :MFCD19982668
InChI Key :ARKKGZQTGXJVKW-VPCXQMTMSA-N
Pubchem ID :11311503

Safety of PSI-6206

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells HepG2 cells Evaluate the cytotoxicity of PSI-6130, no toxicity at concentrations above 100 μM Antimicrob Agents Chemother. 2007 Aug;51(8):2877-82.
Huh-7 cells Huh-7 cells Evaluate the inhibitory effect of PSI-6130 on HCV replication, EC90 was 5.4 μM Antimicrob Agents Chemother. 2007 Aug;51(8):2877-82.
Vero cells Vero cells PSI-6206 reduced viral titre by approximately 1.8-fold at the highest concentration tested. J Virus Erad. 2022 Jun 20;8(2):100074.
HeLa cells HeLa cells PSI-6206 inhibited CVB3 replication with an EC50 of 34.6 μM and a selective index (SI) ≥10. J Virus Erad. 2022 Jun 20;8(2):100074.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rhesus monkeys Rhesus monkeys Intravenous and oral 33.3 mg/kg Single dose Evaluate the pharmacokinetic properties of PSI-6130 in rhesus monkeys, oral bioavailability was 24.0%, and serum half-life after i.v. administration was 4.54 hours Antimicrob Agents Chemother. 2007 Aug;51(8):2877-82.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.84mL

0.77mL

0.38mL

19.21mL

3.84mL

1.92mL

38.43mL

7.69mL

3.84mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories